Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Por um escritor misterioso
Descrição
Risk factor profiles associated with negative outcomes after use of tPA
Tissue Plasminogen Activator for Acute Ischemic Stroke (Alteplase, Activase®)
Alteplase - Wikipedia
Surgical Neurology International
Independent Study Demonstrates Stroke Patients Experience Superior Outcomes with Intra-Arterial Treatment vs. Tissue Plasminogen Activator (tPA)
Tissue-type plasminogen activator - Wikipedia
PDF] The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Full article: Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke
Current Advances in Emergency Department Care of Acute Ischemic Stroke ( Stroke CME and Pharmacology CME) - Calculated Decisions - Emergency Department
Alteplase for Acute Ischemic Stroke - Pharmacy & Acute Care University
de
por adulto (o preço varia de acordo com o tamanho do grupo)
